首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Neuro-oncology

Neuro-oncology杂志,由Oxford University Press出版,于1999年创刊,Quarterly,出版语言English,ISSN:1522-8517,E-ISSN:1523-5866。

投稿咨询
Neuro-oncology
Neuro-oncology
Neuro-oncology
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
13.1
CiteScore
21.1
期刊收录
SCI、SCIE

Neuro-oncology(中文译名:《神经肿瘤学》),ISSN:1522-8517,EISSN:1523-5866,是Oxford University Press出版的国际性学术期刊,创刊于1999年,以Quarterly形式稳定发行,2026年总发文量约184篇。该刊采用非OA开放访问,学科归属为医学 - 临床神经学。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达13.1,2025年期刊CiteScore为21.1,2025年期刊自引率约5.3%,在中科院期刊分区体系中位列医学大类1区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Neuro-oncology长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期一般,3-8周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAGERMANY (FED REP GER)、England、Canada、Japan、France、Italy等为核心发文国家与地区;UNIVERSITY OF CALIFORNIA SYSTEMHARVARD UNIVERSITY、UNIVERSITY OF TEXAS SYSTEM、UNIVERSITY OF TORONTO、DANA-FARBER CANCER INSTITUTE、HELMHOLTZ ASSOCIATION、MAYO CLINIC等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
ONCOLOGY 肿瘤学 CLINICAL NEUROLOGY 临床神经病学
1区 1区
是 否

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
CLINICAL NEUROLOGY 临床神经病学 ONCOLOGY 肿瘤学
1区 1区
是 否

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
CLINICAL NEUROLOGY 临床神经病学 ONCOLOGY 肿瘤学
1区 1区
是 否

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CLINICAL NEUROLOGY SCIE Q1 4 / 296

98.8

学科:ONCOLOGY SCIE Q1 25 / 333

92.6

学科:CLINICAL NEUROLOGY SCIE Q1 7 / 296

97.8

学科:ONCOLOGY SCIE Q1 18 / 333

94.74

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CLINICAL NEUROLOGY SCIE Q1 4 / 286

98.8

学科:ONCOLOGY SCIE Q1 20 / 328

94.1

学科:CLINICAL NEUROLOGY SCIE Q1 4 / 286

98.78

学科:ONCOLOGY SCIE Q1 15 / 328

95.58


中国学者近期发文

1
Methodological concerns on overfitting in a cerebrospinal fluid metabolomics study of leptomeningeal metastasi

Author:Zeng, Yaqin; Sun, Peng

Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag046

2
A reply to two letters to the editor of Neuro-Oncolog

Author:Yang, Chunhui; Wang, Qi

Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag047

3
Efficacy and safety of aumolertinib/icotinib combination therapy for naive EGFR-mutant non-small-cell lung cancer patients with brain metastases: A phase I/II stud

Author:Yu, Min; Chen, Caini; Gong, Youling; Tian, Tian; Li, Yanying; Fan, Hua; Zhang, Lizhi; Deng, Wen; Liu, Yongmei; Peng, Feng; Yu, Yang; Xiu, Weigang; Wang, Yongsheng; Zou, Bingwen; Zhang, Xuanwei; Zhong, Liqiang; Liu, Tianqiong; Wang, Xianfeng; Xu, Yong; Zhou, Lin; Lu, You; Huang, Meijuan

Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag036

4
RGS2 promotes brain metastasis of cisplatin-resistant non-small cell lung cancer through caspase-1/IL-1beta signaling pathwa

Author:Lin, Jiayi; Liang, Lun; Zhu, Xupeng; Liu, Junjie; Lan, Rongfeng; Wang, Zhenning; Zhang, Dan; Wang, Ying; Hu, Xiaoyan; Huang, Shiyu; Qiu, Linhui; Yang, Shilun; Mou, Yonggao; Chang, Junlei; Yu, Min

Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag055

5
Metabolic profiling defines glioblastoma subtypes with distinct prognoses and therapeutic vulnerabilitie

Author:Wu, Fan; Yin, Yi-Yun; Wang, Di; Pan, Chang-Qing; Zhai, You; Yu, Ming-Chen; Wang, Zhi-Liang; Fan, Wen-Hua; Zhao, Zheng; Li, Guan-Zhang; Jiang, Tao; Zhang, Wei

Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noaf294

6
MBD3 deficiency decommissions the nucleosome remodeling and deacetylase complex and orchestrates the epigenetic regulation of gene expression to suppress neuroblastoma progressio

Author:Chen, Chen; Guo, Bize; Wu, Siyan; Zhu, Qinfang; Shi, Hui; Wang, Jinhu; Shu, Qiang; Tao, Ting

Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noaf297

7
Super-enhancer-driven TCF4 orchestrates neuroblastoma metastasis by sphingolipid-dependent membrane remodeling and ITGB1-FAK activatio

Author:Lou, Enzhe; Jiang, Liling; Zheng, Yueyuan; Zhuo, Ran; Zhou, Huan; Hu, Shiwen; Shi, Chunxia; Zhang, Haichuan; Li, Xinyue; Jiang, Lizhen; Mao, Qiong; Liu, Aochu; Liu, Bingyuan; Fang, Jinxin; Pan, Jian; Shi, Xianping

Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag021

8
PEAKS activation by PROTAC EPIC-0726 potentiates temozolomide in glioblastoma via K63/K48 ubiquitination-dependent ERK/AKT suppression and p21 stabilizatio

Author:Hong, Biao; Su, Dongyuan; Cui, Xiaoteng; Zhao, Jixing; Wang, Qixue; Zhan, Qi; Yang, Eryan; Yang, Shixue; Ju, Jiasheng; Huang, Yanping; Cheng, Chunchao; Ding, Yaqing; Xu, Hanyi; Cui, Longtao; Zhao, Yilin; Zhao, Xun; Liang, Siwen; Liu, Yuhao; Kang, Chunsheng

Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noaf253

9
Meningioma microenvironment harbors a rich immune landscape that evolves with biological stat

Author:Guo, Xiaopeng; Moynihan, Zachary A.; Driver, Joseph; Patel, Ruchit, V; Bhave, Varun M.; Maury, Eduardo A.; Knelson, Erik H.; Guo, Hong; Lin, Jia-Ren; Coy, Shannon M.; Wang, Anthony; Gupta, Saksham; Hoffman, Samantha E.; Dunn, Ian F.; Dunn, Gavin P.; Petti, Allegra; Choi, Bryan D.; Choudhury, Abrar; Raleigh, David R.; Wei, Kevin; Reardon, David A.; Barbie, David; Lederer, James A.; Santagata, Sandro; Bi, Wenya Linda

Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag022

10
Methodological considerations for large language model-based symptom extraction in neuro-oncology electronic health record

Author:Wang, Xindi; Chang, Zhaoxin; Dong, Hao; Mu, Guangjing; Li, Xingang; Han, Mingzhi

Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag009


在线咨询

Neuro-oncology

国际简称:NEURO-ONCOLOGY参考译名:神经肿瘤学

年发文量:184 CiteScore:21.1 是否预警:否 Gold OA文章占比:39.62% 研究类文章占比:91.30%

杂志社联系方式:OXFORD UNIV PRESS INC, JOURNALS DEPT, 2001 EVANS RD, CARY, USA, NC, 27513

Neuro-oncology